For example, low expression of ID2 and its associated gene signature are correlated with poor prognosis in MLL-rearranged acute myeloid leukemia, where it acts as a negative regulator of leukemia stem cell potential33. This evidence concerns the gene KMT2A and acute myeloid leukemia.